AIM ImmunoTech green-lit by the FDA for its trial to treat coronavirus patients with cancer May 26, 2020 SkiHigh Marijuana Medical Benefits 0 AIM ImmunoTech Inc (NYSEAMERICAN:AIM) CEO Tom Equels tells Proactive the FDA has approved the first human trial of the company’s lead drug Ampligen …
Be the first to comment